1. Lungenfibrose: Eine Komplikation des Diabetes?
    Stefan Kopf et al, 2015, Deutsches Ärzteblatt Online CrossRef
  2. RAGE may act as a tumour suppressor to regulate lung cancer development
    Shuangshuang Wu et al, 2018, Gene CrossRef
  3. Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD
    Francesco Nucera et al, 2021, Current Medicinal Chemistry CrossRef
  4. Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review
    Shouichi Okamoto et al, 2017, BMC Cancer CrossRef
  5. Elevated Expression of the RAGE Variant-V in SCLC Mitigates the Effect of Chemotherapeutic Drugs
    Bindhu K. Madhavan et al, 2021, Cancers CrossRef
  6. All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses
    Elizabeth A. Oczypok et al, 2017, Paediatric Respiratory Reviews CrossRef
  7. The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
    Narasimha M. Beeraka et al, 2021, Cancers CrossRef
  8. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
    Takumi Kinjo et al, 2020, Scientific Reports CrossRef
  9. Effect of RAGE gene polymorphisms and circulating sRAGE levels on susceptibility to gastric cancer: a case–control study
    Taijie Li et al, 2017, Cancer Cell International CrossRef
  10. Determination ofSIRT1rs12778366,FGFR2rs2981582,STAT3rs744166, andRAGErs1800625 Single Gene Polymorphisms in Patients with Laryngeal Squamous Cell Carcinoma
    Virgilijus Uloza et al, 2019, Disease Markers CrossRef
  11. Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases
    Wei Liu et al, 2019, Molecular Genetics & Genomic Medicine CrossRef
  12. Long non‐coding RNA AGER‐1 functionally upregulates the innate immunity gene AGER and approximates its anti‐tumor effect in lung cancer
    Zihua Pan et al, 2018, Molecular Carcinogenesis CrossRef
  13. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma
    Jiayi Zhang et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
  14. Protein transduction therapy into cochleae via the round window niche in guinea pigs
    Hiroki Takeda et al, 2016, Molecular Therapy - Methods & Clinical Development CrossRef
  15. Diabetes und restriktive Lungenerkrankungen/Fibrose
    S. Kopf, 2018, Der Diabetologe CrossRef
  16. Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia—A case-control study from Iran
    Ebrahim Eskandari-Nasab et al, 2017, Nucleosides, Nucleotides & Nucleic Acids CrossRef
  17. High glucose promotes tumor cell proliferation and migration in lung adenocarcinoma via the RAGE‑NOXs pathway
    Yuan‑Fan Liao et al, 2018, Molecular Medicine Reports CrossRef
  18. The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
    Ying‐Erh Chou et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
  19. Oxidation, glycation and glycoxidation—The vicious cycle and lung cancer
    Saheem Ahmad et al, 2018, Seminars in Cancer Biology CrossRef
  20. The role of high‐mobility group protein box 1 in lung cancer
    Xiao‐Jin Wu et al, 2018, Journal of Cellular Biochemistry CrossRef
  21. Breath of fresh air: Investigating the link between AGEs, sRAGE, and lung diseases
    Charlotte Delrue et al, 2024, Glycation CrossRef